Publication date: June 2023Source: Neuroscience & Biobehavioral Reviews, Volume 149Author(s): Samuel Weiss-Cowie, Paul Verhaeghen, Audrey Duarte
Serotonin, Norepinephrin, Dopamine – Combining Medication against Depression Christian Jonathan Haverkampf, M.D. A monotherapy or a combination of antidepressants that affect all three monoamines serotonin, dopamine and norepinephrine together have led to some positive results in cases of treatment-resistant depression, while some promising substances that could be used as monotherapy are still in the early
Serotonin, Norepinephrine, Dopamine – Combining Medication against Depression Read More »
Psychopharmacological Frontiers Christian Jonathan Haverkampf, M.D. New developments in psychopharmacology have driven much of the progress over the last decades. This article discusses new developments in the area of antidepressants and antipsychotics. Keywords: depression, SSRI, SNRI, ketamine, glutamate antagonist, NMDA, scopolamine, magnesium, glutamine, CP-AMPA, serotonin, norepinephrine, dopamine, antidepressants, major depressive disorder, medication, treatment psychiatry Table
Psychopharmacological Frontiers (1) Read More »
